Dapagliflozin reduced the combined risk of worsening heart failure

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.

Leave a Reply

Your email address will not be published. Required fields are marked *

Read More with More InformationMCQs & Info-Bits

Enter the Forum

Enable Notifications OK No thanks